D. E. Shaw & Co., Inc. Olink Holding Ab (Publ) Transaction History

D. E. Shaw & Co., Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.81 - $25.14 $103,641 - $119,465	4,752 Added 29.85%	20,669 $485,000
Q4 2023 Feb 14, 2024	SELL	$14.29 - $25.95 $785,021 - $1.43 Million	-54,935 Reduced 77.53%	15,917 $400,000
Q3 2023 Nov 14, 2023	BUY	$14.45 - $20.34 $196,765 - $276,969	13,617 Added 23.79%	70,852 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$17.13 - $23.74 $89,110 - $123,495	5,202 Added 10.0%	57,235 $1.07 Million
Q1 2023 May 15, 2023	SELL	$19.34 - $24.11 $201,348 - $251,009	-10,411 Reduced 16.67%	52,033 $1.17 Million
Q4 2022 Feb 14, 2023	BUY	$12.64 - $25.52 $154,170 - $311,267	12,197 Added 24.27%	62,444 $1.58 Million
Q3 2022 Nov 14, 2022	BUY	$12.14 - $18.42 $609,998 - $925,549	50,247 New	50,247 $610,000
Q4 2021 Feb 14, 2022	SELL	$18.0 - $34.82 $397,080 - $768,129	-22,060 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.42 - $37.93 $217,361 - $352,028	9,281 Added 72.63%	22,060 $535,000
Q2 2021 Aug 16, 2021	BUY	$26.65 - $39.47 $340,560 - $504,387	12,779 New	12,779 $440,000

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.